Drugplain

perrigo allergy d 5 mg/1

loratadine, Pseudoephedrine sulfate · TABLET, FILM COATED, EXTENDED RELEASE · L. Perrigo Company

No Recall History
Plain English

perrigo allergy d is a tablet, film coated, extended release containing loratadine, pseudoephedrine sulfate at 5 mg/1, taken oral. Manufactured by L. Perrigo Company.

Key Facts

Brand Name
perrigo allergy d
Generic Name
loratadine, Pseudoephedrine sulfate
NDC Code (Product)
0113-7777
Manufacturer
L. Perrigo Company
Strength
5 mg/1
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Marketing Status
Application #
ANDA076050
Marketing Start
10/08/2021

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

condition aggravated1 reports
depressed mood1 reports
depressive symptom1 reports
drug interaction1 reports
drug-disease interaction1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • sneezing • itchy, watery eyes • runny nose • itching of the nose or throat • temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies • reduces swelling of nasal passages • temporarily relieves sinus congestion and pressure • temporarily restores freer breathing through the nose

Dosage & Administration

Directions • do not divide, crush, chew or dissolve the tablet adults and children 12 years and over 1 tablet every 12 hours; not more than 2 tablets in 24 hours children under 12 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Warnings

Warnings Do not use • if you have ever had an allergic reaction to this product or any of its ingredients • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have • heart disease • thyroid disease • high blood pressure • diabetes • trouble urinating due to an enlarged prostate gland • liver or kidney disease. Your doctor should determine if you need a different dose. When using this product do not take more than directed. Taking more than directed may cause drowsiness. Stop use and ask a doctor if • an allergic reaction to this product occurs. Seek medical help right away. • symptoms do not improve within 7 days or are accompanied by a fever • nervousness, dizziness or sleeplessness occurs If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-

Frequently Asked Questions

What is perrigo allergy d used for?

perrigo allergy d contains loratadine, Pseudoephedrine sulfate. It is a tablet, film coated, extended release taken oral. Consult your doctor for specific uses.

Is perrigo allergy d a controlled substance?

perrigo allergy d is not classified as a controlled substance by the DEA.

What is the generic name for perrigo allergy d?

The generic name for perrigo allergy d is loratadine, Pseudoephedrine sulfate. There are 11 other brand versions of loratadine, Pseudoephedrine sulfate.

What is the NDC code for perrigo allergy d 5 mg/1?

The NDC (National Drug Code) for perrigo allergy d 5 mg/1 is 0113-7777, listed by L. Perrigo Company.